Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

Recruiting

Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility StudySiegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

Sponsor:

MiRus

Code:

NCT06680427

Conditions

Aortic Stenosis Symptomatic

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Siegel Transcatheter Aortic Valve (TAVR)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-24. This information was provided to ClinicalTrials.gov by MiRus on 2025-02-18.